Chris Boland - Avivagen CFO
VIV Stock | CAD 0.01 0.00 0.00% |
CFO
Mr. Chris Boland was appointed as Chief Financial Officer of Avivagen Inc., with effect from July 12, 2012 since 2012.
Tenure | 12 years |
Address | 100 Sussex Drive, Ottawa, ON, Canada, K1A 0R6 |
Phone | 613-702-2908 |
Web | https://www.avivagen.com |
Avivagen Management Efficiency
The company has return on total asset (ROA) of (1.9344) % which means that it has lost $1.9344 on every $100 spent on assets. This is way below average. Avivagen's management efficiency ratios could be used to measure how well Avivagen manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to climb to 2.28 in 2024, whereas Return On Assets are likely to drop (4.20) in 2024. At this time, Avivagen's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 2.4 M in 2024, whereas Other Current Assets are likely to drop slightly above 24.1 K in 2024.Similar Executives
Found 3 records | CFO Age | ||
David Watson | Medical Facilities | 58 | |
Scott Morstad | Medical Facilities | N/A | |
Michael Salter | Medical Facilities | 66 |
Management Performance
Return On Asset | -1.93 |
Avivagen Leadership Team
Elected by the shareholders, the Avivagen's board of directors comprises two types of representatives: Avivagen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Avivagen. The board's role is to monitor Avivagen's management team and ensure that shareholders' interests are well served. Avivagen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Avivagen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tracy BVSC, Director Manager | ||
David Hankinson, Executive Director | ||
Louis Hui, Director - Business Development | ||
Chris Boland, CFO | ||
David Allan, Director | ||
Ira Levy, Interim Officer | ||
Amin Khalifa, Independent Director | ||
Aubrey Dan, Director | ||
Cameron Groome, CEO and President and Director | ||
Vanessa Grant, Director | ||
Andrew Basek, Director of Investor Relations | ||
Drew Basek, Director of Investor Relations | ||
Paul Mesburis, Lead Director | ||
James Nickerson, President Innovation | ||
Graham Burton, Co-Founder, Director of Commercialization Science and Director | ||
G Anthony, Independent Director |
Avivagen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Avivagen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Asset | -1.93 | ||||
Operating Margin | (10.47) % | ||||
Current Valuation | 7.61 M | ||||
Shares Outstanding | 77.69 M | ||||
Shares Owned By Insiders | 1.11 % | ||||
Number Of Shares Shorted | 3.2 K | ||||
Price To Earning | (7.32) X | ||||
Price To Sales | 0.54 X | ||||
Revenue | 939.17 K | ||||
Gross Profit | 400.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GOOG | Alphabet Class C | |
S | SentinelOne |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Avivagen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Avivagen Stock analysis
When running Avivagen's price analysis, check to measure Avivagen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avivagen is operating at the current time. Most of Avivagen's value examination focuses on studying past and present price action to predict the probability of Avivagen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avivagen's price. Additionally, you may evaluate how the addition of Avivagen to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |